After the EGFR antibody modified on the surface of the composite microspheres spontaneously binds with EGFR in thyroid cancer and breast cancer cells, EGFR is highly expressed in cancer cells, making the microspheres located at the cancerous site [7]. This evidence concerns the gene EGFR and thyroid gland carcinoma.